Machine Learning Approach for Cancer Entities Association and Classification
Not on the map. Why?
Abstract (arXiv)
According to the World Health Organization (WHO), cancer is the second leading cause of death globally. Scientific research on different types of cancers grows at an ever-increasing rate, publishing large volumes of research articles every year. The insight information and the knowledge of the drug, diagnostics, risk, symptoms, treatments, etc., related to genes are significant factors that help explore and advance the cancer research progression. Manual screening of such a large volume of articles is very laborious and time-consuming to formulate any hypothesis. The study uses the two most non-trivial NLP, Natural Language Processing functions, Entity Recognition, and text classification to discover knowledge from biomedical literature. Named Entity Recognition (NER) recognizes and extracts the predefined entities related to cancer from unstructured text with the support of a user-friendly interface and built-in dictionaries. Text classification helps to explore the insights into the text and simplifies data categorization, querying, and article screening. Machine learning classifiers are also used to build the classification model and Structured Query Languages (SQL) is used to identify the hidden relations that may lead to significant predictions.
Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 5 of its 36 references that are in the map. First posted on arXiv 30 May 2023.
Builds on
5 of 36 references.
References · 5
- 2017Attention Is All You Needcited by 60,361
- 2018BERT: Pre-training of Deep Bidirectional Transformers for Language Understandingcited by 40,399
- 2016Bag of Tricks for Efficient Text Classificationcited by 876
- 2017Natural Language Processing: State of The Art, Current Trends and Challengescited by 114
- 2022Machine Learning-based Lung and Colon Cancer Detection using Deep Feature Extraction and Ensemble Learningcited by 13
Built on by
Not cited yet.